RondinX

Microbiome Drug Discovery System

Health Tech & Life Sciences
Acquired (Inactive) by BiomX on Dec 2017 - closed due to acquisition

Company Overview

Snapshot

Founded in May 2015 by Guy Harmelin, Rafi Gidron, and Alon Hirsch, RondinX operated with 1–10 employees. The company secured $2.5M in total capital across one funding round from two investors. A significant milestone was its acquisition by BiomX in December 2017.

Business overview

RondinX developed a target and drug discovery platform focused on creating solutions within the microbiome therapeutic and companion diagnostic sectors. Its core technology, exclusively licensed from YEDA, utilized a proprietary, cloud-based computational pipeline that processed raw metagenomics data to derive static and dynamic strain-level insights into bacterial ecosystems. The company operated within the Health Tech & Life Sciences sector, specifically targeting the pharmaceutical industry.

Strategic signal

In December 2017, RondinX was acquired by BiomX, a move that significantly boosted BiomX's microbiome discovery and development capabilities. This acquisition signals a strategic validation of RondinX's computational platform and its potential to accelerate drug development in the microbiome space, indicating a successful exit and integration into a larger biotech entity.

Company Intelligence Q&A

When was RondinX acquired?
RondinX was acquired by BiomX in December 2017.
What was the primary purpose of BiomX acquiring RondinX?
BiomX acquired RondinX in December 2017 to enhance its microbiome discovery and development capabilities, integrating RondinX's computational platform.
What is RondinX's core technology?
RondinX's core technology is a peak-to-trough family of algorithms, exclusively licensed from YEDA, which forms a proprietary, cloud-based computational pipeline for analyzing raw metagenomics data to understand bacterial ecosystems.
What was RondinX's total capital raised before its acquisition?
RondinX raised $2.5M in total capital across one funding round in March 2016, with participation from investors including Elevator Fund and 8VC.
Which investors participated in RondinX's funding round?
In March 2016, RondinX received funding from investors including Elevator Fund and 8VC.